中華民國心臟學會 · 2020. 8. 7. · 48 coronary aneurysm 49 coronary angiography & 50...
TRANSCRIPT
45
�� !"#$%
�� !�"#$%&'()*+,
��� ! �� !"#"$!%&�� !"�� !"#$
��� ! �� !"�#$%&'()*+,-
��� ! �� !"#
�� !"�� !"# �� !"#$!%&'(
�� !" �� !"#$!%&'!�()!*+,!-./!012!
�� !"#$!%&'!()*!+,-!./01
�� !" �� !"#$!%&'!()*!+,-.
�� !"�� !" �� !"#$!%&'!()*!+,-!+./!012!
�� !"#$!"%&!'()!'*+!,-.!,/0!
�� !"#$!%&'!()*!+,-!./01
�� !"�� !"#$!%&'!()*!+,-!./01
�� !" �� �� !"#$
�� �� !"#$
�� �� !"#$%&'()
�� �� !"
�� !"#$�� !"#
�� !"#$!%&'�� !
�� !"#$%&'()*+,-
��� ! �� !
���� !"�� !"#$%
1. �� !"#$%& APCC �� !"#$%&'( 12� 13-16�� !"#$%
�� !" Live demonstration�� !"#$%&'()*+,-./�WHF��
�� !"#�ACC��� Joint sessions�� !"#$%&�ESC��� !"#
�� !"#$%&'()*+,-./0012345678)9:;<=>?
�� !"#$%&'()*+,-./012345678*9:";<,=>
�� !�"#
�� !"#$
�� !
96 � 6 ��46
�� !�"#
�� !"#$
�� !
�� !"#$%&'()*+�,-./0!123$45678��9:%;
� 12�� !"# live demo�� !"# e-mail�� !"#$%&'()*+,
�� !"# APCC� live demo�� !"#
2. � APCC�� !"#$%&'()*+,-./!�APSC��� !"#$%&
�� !"#$%&'()*+,&-.'/0123456789:;<=>?
�� !"#$% free paper�� �!"#$%&'()*+",-./0123
�� !"#$%&'()*+,-./0123456
3. ��� ! "# $%& "'()*+,-./01234 MSCT�� !"
�� !"#$%&'()*+$%,-.+/01234 MSCT�� !"#$
�� !"#$%&'()*+,-./01234567%89:;<=5-3>
4. �� !"#$%&'(�� !"#$%�� !"#$%&'()� !*#
�� !"#$%&'()*+,-./0123456&789:;,<=>?
�� !"#$%&'()*+,-./0123456
��� !"#$!%&'()*+,-./0123456,,7()8
�� !"#$�� !"#$%
�� �� !"#$!%&'()*+,-./0
� �� !"#
�� �� !"�� !"#$%&'()*+,-.!/0123456!"78
�� !"
� �� !"#
�� �ST�� !"#$%&'()*+,��
�� !"#$%&'()*!+,-./012345623789:;<=
�� !"#$%& ACC/AHA/ESC guideline�� !"#$%&'()*+,
�� !"#$%&'()�� &*+,-./0123456789:;<
�� !"#$%&'()*+,-./0'12345678!"�
�� �� !"#$%&'()*+,�-./0123456789:;<
�� !"#$%&'()*+,-./0123456)789:;<=>6
47
�� !"#!$%&'()*+,-./01
�� !"#$%&'()*+,-./012�3456789:;<(=�
�� !"#$%&'()*+,-
�� �� !"#$%
1.�� !"#$%&'()*+,-�� 96� 8� 4-5� 11-12�� !"#$
�� !"#$%&'()*+,�� !"#$%&'()*+,-./0
�� !"#$%&'()*+,#-./0123456
2.�� !"#$%&'()*�� 96� 10� 18-20�� !"#$%&
3.�� !"#$%&'()�� 96� 12� 13-16�� !"#$%&'()*
���� !"#$
����� !"#
1. �� !"#$%&'()
�� �� !"#$%&'()*+,-./01234*5,-./6.0
�� !"#$%&'(")*+,-./012345#$6-78
�� !"#$%&'()*+,-,./
��� 1�4� 3�� !"#$%&'(Heart and Circulation�� !"#$%
�� !"�� !"�� !"#$%&'()*�107����
�� ICD-10"�� !"#$%& " �� !"#$%&'()*+,
2��� !"#$%&'()*+,-./0123
3��� !"#$%&'()*+� ,-!"./0123
�� !"#$%&'()*+,-�� !"�
����� !"#$%&'()*
1. �� !"#$%&'()*+,-./012345678
��� !"#$%&'()*+,-./0
2. �� !"#$%&'()*+,-./0
��� 1��� !"#$%&
�� �� !"#$%&'�� !"#$%&'�� !"#
�� !�"#
�� !"#$
�� !
96 � 6 ��48
�� !�"#
�� !"#$
�� !
�� !"#$%&'()*+,-./01234567
�� !"#$%&'()*+
� ��
���� !"#$%&'()*+���� !�� !"#
�� !"�
��� !�� !"#$%&'()*+�� !"#$%&
���� !"�� !"�� !"��
��� !"#$%�� !"#$%&'()*+,-.�
��� !"#$�� !"#$%&'()*+,-./0�
� ��
���� !"#$%&'�� !"#$%&'()*+,-
�� !"#$%&'$()*+,-. !"#/01
��� !"#$%&'()*+,-./01&2(3456
�� !"#$%&'()*#+,-./012�� !"
�� !"�� !"��
��� !"#$%�� !"#$%&'()�
2��� !"#$%&'()�� !"#$%�� !"#$%&
�� !"#$%&'()*+�� !"#$%&'()��
�� !"# $%&'()*+,-./0123456789:
�� !"#$%&'()*+,-.%/0123456789
�� !"#$%&'()*+, APCC�� !"#$%&'()
3��� !"#$%&'()*+,-./0 123456789
�� !"#$�%&'()*
4��� !"#$%��&'()*+,�-./ APCC��
3. ICHHN�� !"#$
��� 1�� ICHHN �� !"#$%&%'()*+,-./012345
�� !"#$%&'(#)*+,-./0123456�#*
�� !"#$%&' ()*+ ICHHN �� !"#
2�ICHHN 2007��� !"#$%&'()* +,-./$%&0
49
�� !"#$%&'()*+,-�� !"#$%&'( ICHHN
�� !"�
3�ICHHN �� !"#$%&'()*+,�� !"#$�� !
�� !
4. �� !�� !"#$�
��� 1��� !"#$%&'()*+,-./012345678.9
APCC�� !"#$%&
2��� !"#$%&' APCC�� !"#$%&'()*+,-.
�� !"#$%&'()*+
����� !"#$%&
1. �� 16th APCC Pediatrics Live Demo Session��
��� 1�Panelists:�� !"#$%&'( Short Lecture�
Teiji Akagi: Pediatric Cardiac Intervention in Japan
��
��
��
�� !PTA
�� !ASD� ICE
��
�� !"#$%TEE
��
2�Demo Site: �� !"#$%&'()*+,#-./0
�� !"
Ziyad M. Hijazi�USA�
Mazeni Alwi�Malaysia�
Qi-Ling Cao�USA�
��
��
�� !�"#
�� !"#$
�� !
96 � 6 ��50
�� !�"#
�� !"#$
�� !
2. APCC�� !"
APCC �� !�S31-Surgery in Congenital Heart Diseases��� !"#$%&
�� !"#$ Hiromi Kurosawa�Japan��� !"#$%&'()*+,-
��
����� !"#
1. �� !"#$%&
�� �� !"#$ 95.11.10�� !"#$%&'()*+,-. /0
�� !"#$ 95� 8� 12�� !"#$%&�� !"#$%&
�� !"#$%&'()* %+,-./012345#$�
��� �� !"
2. �� !"#$
�� �� !"#$%&'()*+,-./012�95.012-97.12���
�� !"#
��� �� !"#$%&'()*+,-./01234�5%&6789
�� !"#$%&'()*+ ,-./0
3. �� !"#!$%&
��� �� !"#$%&'()'*+,-./012345
�� �� ! �� !"#
1 �� �� !�"�� !"#$ 96.03.03
2 �� �� !�"�� !"# 96.03.15
3 �� �� !�"�� !"# 96.03.15
4 �� �� !�� !"# 96.04.24
5 �� �� !�� !"# 96.04.30
6 �� �� !�� !"# 96.05.10
7 �� �� !�� !"# 96.05.14
51
4. �� Dr. Kim �� !"#$%&'()*+,
��� �� !"#$%&'()*+#,-./012345678*+#
�� !"#$
����� !"#$%
1. 96.05.06 CTA�� !"
��� 96.05.06�� !"#$%&'()*+,-./&012345 CTA
�� !"#$%&'( 519��� !" ==>300�� !"#$% ==>
209�� !"#$% ==>10���� !"#$%&�'()* Dr.�
�� Dr.�� !"#$%&'()*+
2. 16th APCC�� !"#$%&'(
��� 1��� !"#$%&'()*+,-./0 ESC� WHF� ACC..�
Joint Session�� !"#$%&'( )*+,-.
2��� APCC Moderator �� !�� �� ! 16th APCC�� !"
�� !"#$%&
3. �� !"#"$%&'"()*+,
��� 1��� Session� 50�� !"#$%&'()*+,'-./ -.
�� 13�� /�� !"#$11�� !"#$%&'()*#+
�� !"#$%&'()*+,-
2��� !"#$%
�Guideline�
A. �� !"#$%
Guideline for the Diagnosis and Management of Chronic Heart Failure
Moderators:�� !"#$
Overview of Chronic Congestive Heart Failure ��
Non-pharmacological Management for Chronic Heart Failure��
Pharmacological Management for Chronic Heart Failure ��
Panel Discussion
�� !�"#
�� !"#$
�� !
96 � 6 ��52
�� !�"#
�� !"#$
�� !
B. �� !"#$%&
Guideline for the Management of Hypertension
Moderators:�� !"#$
Comparison of hypertension guidelines from Asian countries��
Introduction to the British Hypertension Society IV guidelines��
Comparison of international hypertension guidelines: JNC-7,
WHO/ISH, and ESH/ESC guidelines��
Panel Discussion
C. �� !"#$%&
Guideline for the Management of Angina
Moderators:�� !"#$
Guideline for Stable Angina ��
Guideline for Non ST-Elevation Acute Coronary Syndrome
�NSTE-ACS���
Guideline for ST-Elevation Myocardial Infarction�STEMI� ��
Panel Discussion
�Advance�
A. �� !"#$%&'
Clinical Application of MDCT
Moderators:�� !"#$
Recent Advance of MDCT��
�� !"
How to apply MDCT in clinical practice ? ��
MDCT, Thallium 201 perfusion scan, Stress
echocardiography, which is better ?��
Panel Discussion
53
B. �� !"#$%&
Drug Eluting Stents
Moderators:�� !"#$
Limus� Eluting Stents�Cypher, Endeavor, Xience V���
Paclitaxel� Eluting Stents�Taxus etc�, and Issue of
DES Thrombosis ��
Next Generation DES�Genous, Biodegradable, Bioabsorable
Stents���
Panel Discussion
4. 96�� !"#$%&'()*+,-./0
��� 1��� ! NIH �� !"#$%&'()*+,-./01234
�� !"#$%&'()*+,-./01234567� !
�� !"�#$%&'()*+,"�-./01
2��� !"#$%&'()*+,-./01234# !5,6
�� !"�� !"#$%�� !"#$%&'()�*+,
�� !"#$%&' ()*+,
3��� !"#$ A �� 20�� !"#..�� !"#$%&'(
��
4��� !"#$%&'()*+, Fellow�� !"#$%&'()
��
5��� �� �� !" 96� 8� 4~5�� 8� 11~12�
6��� !"#$%&'()*+
5. �� �� !"#$%&��� !"�� !"#$
�� !1��� !" 16th APCC�� !"#$%&'()*�� !"#
�� �� !"#$%&'()*+#",'-./012�3
�� ! 16th APCC�� !"#$%&'(
2��� !" 7� 30�� !"# 9�� !"#$%&'()*+
�� !"#
�� !�"#
�� !"#$
�� !
96 � 6 ��54
�� !�"#
�� !"#$
�� !
3��� !�"�� !"�
����� !"#$%&'
1. 16th APCC Live Course�� !"
�� Live demonstration�� ! 96� 12� 14� 16� 3��12/16� EP�� !�
�� demo�� !"#$%&'()*� +,-� +./01� 23
�� !"#$%&'()*+,-./0
2. AMI Guideline�
�� �� !�� !"#$%&'()*%+�� !"#$%&'�ST
�� !"#$%&'()*+,�� !"#$%&'()*+,-
�� !"#$%&'()*+,-./0123456
��� �� ! e-mail�� !"#$%& 6/15�� !"#$%&'()*
�� !"#$%& ACC/AHA � ESC�� !"#$%&'()*+
�� !"#$%
3. �� !"#$%&'()*+,-./0
�� �� !"#$%&'()*+,-�./�01234.56789
�� !"#$%%&'()*+,-./012345$%6789
�� !"#$%
��� �� !"#�� !"#$%&'()*+,-�� !"#$%&
�� !"#$%&'()*+,-
4. �� �� !" ticlopidine� clopidogrel�Plavix��� ! aspirin�� !"
67%�� !"#$��
��� �� !"#$%&'()*+,-./01234567#89.:
� 67%�� !"#$
55
�� !"#$
���2007 APCC�� !"#$
�� �� !"#$%&'( 96� 12� 13-16�� !"#$%&'()* 13
�� Opening Ceremony & Welcome Reception�� 9� plenary speech, 29�
symposia� 16� free papers�� !"#$%&'()*+,-./"0
�� !"#$%&'()*+,-!./0123456789!:;
�� !"#$%&'()*+,-./
��16th APCC�� !"#$�� !"
� �� �� !"# APCC�� !"#
���Vice President�Zone 1�of APSC�� !"
�� �� !"#$#%&'()*+,�Zone 1, 2, 3��� !"#$%
�� Vice-president��
� �� �� !"#$%&'() President-elect�� !"#$%&'()*+
�� !"#$%&'()*+, Zone 1� Vice President�
����� !"#$%&'()�� !"#$%&
�� �� !"#$%&'()!"#*+,-./
��� ������ ! ���� !" ����
�� �� !"#$% �� !
�� !"#$!
�� !"#
�� !"#$% �� !"22�� �� !"
�� ! �� !"#$%&' �� !"
�� !"# �� !"#$%&' �� !"
��� !" 25�� �� !"
���
�� !�"#
�� !"#$
�� !
96 � 6 ��56
�� !�"#
�� !"#$
�� !
��� ������ ! ���� !" ����
�� �� !"#$% �� !" 21�� �� !"
�� �� !"#$%&' �� !"
�� !"# �� !"#$%&' ��
�� !
�� �� !"!#$ �� ! �� !
��
�� !"#
�� !"#$% �� ! �� !
�� !
�� !"#
�� !"!#$ �� !"#$�� �� !"
�� �� !"#$%&' �
�� !"#$ �� �� !"
�� �� !"!#$ �� ! ��
��
�� !"#
�� !"#$ �� ! ��
�� !"#
�� !"#$ �� ! ��
�� !"#
�� !"#$% �� ! ��
�� !"#$%
�� �� !"# �� !"21�� �� !"
�� !"# �� !"#$%&' �� !"
�� !"#$%&' �� !"
�� !"#25�� ! �� !
�� !"#$%&'
��
57
��� ������ ! ���� !" ����
�� �� !"#$ �� !"22�� �� !"
�� !"# �� !"#$%&' �� !"
�� !"#$%&' �� !"
��� !" 25�� �� !
���
�� !"# �� !"22�� �� !"
�� !"# �� !"#$%&' �� !"
�� !"#$%&' ��
��� !" 25��
���
�� !" �� !
�� !"#
� �� �� !"#$%&'()*+ " �� !"#$%& " �� !"#$
�� !"#$%&'()*+,-./0&'1023456789:
�� !"#
����� !"#$%&'()*+,-./0�� !"#$%&�
�� �� !96� 9� 15��� !"�� / �� !"#$
�� !96� 10� 7��� !"�� / �� !"#$%&
� �� ��
����� !"#$%&'()*+�� !"#$%&�
�� ���� !"#$%&'()�� �!"#�$%#&'()
�� !"
�� !"#$! "%&'()*+,-./01234+567
�� !"#$%&'(�
�� !�"#
�� !"#$
�� !
96 � 6 ��58
�� !�"#
�� !"#$
�� !
�� !"
�� !"#$! "%&'()*+,-./01234+567
�� !"#$%&'(�� !"#$%&'()*+,-��
�� !"#$%&'()*+,�
� �� �� !"#$%&'()*+,-./012
����� !"#$%"&'()*+,�� !"#$%&
�� �� !"#$%&%'()*+,-./012345"#$%&%6
�� !"�� !"#$%&'&�96.08.23���� " �� ! " ��
�� !"#$%&'
��������� �� �!�" ����
�� !"# �� !"#$
�� !"#$ �� !"#$
�� !"# �� !"#$
�� !"# �� !"#$
�� !"#$%&'%( �� !"#$ �� 96��
� �� ��
����� !"#$%&'()*+,�� !"#$%&'()*
�� �� !"#$%&'()*+,-�./�01234.56789:
�� !"#$$%&'()*+,-./01234#$56789:
�� !"#
�� �� !"#�� !"#$%&'()*+,-�� !"#$%&'
�� !"#$%&'()*+,
� �� �� !"#$%&'(
59
�� !"#$%
�� !"#$%&'()*+,-
���� !"#$%&
1��� !"#$%&
2��� !"#$%&'�� !"#$%&'()*+,-
�� �� !"#$%&�� �� !"#$%&'()
3��� !"#$%&'()*+,-./01234�Under
Supervision��
�� �� !"#�� !"�� �� !"#$%&'(
�� !"#$%��&!'
�� 75�� !"#$%&'()*+,-./0�� !
�� !"#$%&'()*+,�
�� 97� 1� 1�� !"#$%&'(
1��� !"#$%&�� 97� 1� 1�� !"#�
2��� !"#$%&'()*+,-./01234567
��� !"#$%&"'()*+,�� �� !"#�
���� !"#$%&'()*�� !"#$%&'()��
�� !"#$%&'()*+,-.
����� !"#$% &'()*+,-.�� !"#$%&
�� �� !"#�� !"#$�� �� 60�� �� !"#$%&
�� !"#$%&'()*+ ACC/AHA/ESC�� paper��� !"#
�� !"�� !"#�$%&�� paper�� !"#$%& paper
�� !"#$%&'"(�� !"#$%&'()*
� �� �� !Oral� Poster�� !"#$%&'()*+, -./012
�� !"#$%&'()*+,
����� !"#$%�!&'()*!+�� !"
�� �� !"#$%�!&'()*!+��
�� !�"#
�� !"#$
�� !
96 � 6 ��60
�� !�"#
�� !"#$
�� !
1��� !"#$%&'()*"#$%+,-./0123456
2��� !"#$%&'()*+,-.(*/01"2�primary PCI��
�� 24�� !"#$%&'(#()*�� !"#$%�� !
�� !"�� !"#$%&'()*�� !"#$
3��� !"#$%&'()*+,-./0123456�� !"
��
� �� �� !"#$%&'()
���AMI & PCI registry �� !"�� !"#$%&'()*
�� (1) �� !"#$%&'�� !"
(2) AMI&PCI �� !"#$%&'()*+,-./0,-12345
�� !"#$%&'()*+,-./0123456789:;
�� !"#$%&'()*+",-&./01)234()56
�� ACC/AHA �� !"�#$%&'()*+,-. guideline�
�� !"#$%&'()*+,-./01234567#89:
�� !"#$%!&'(#)*+,-./0123456789
�� !"#
� �� �� !"#$%&'()*+,-./012%3
�� ��� !"#$� IVUS���� !�� !"#$%&'()*
�� �� !"#$%&�� !"#$�IVUS���� !"#$%&'(
��
1��� !"#$%�&'()�*+(,-!"#$./01%,2
�� !"�#$%&
2��� !"#$%&'()*+,-./0123
3��� !"#$%&'()*+,-./0
4��� !"#$%&'()*+,-./012+3456789:
�� !"#$%&' IVUS �� !
5��� !"#$%&'()*+,-.
6��� !"#$%&'()*+,-./0123456)*7
61
7��� !"#$%&'(�DCA��� !"#$
�� �� IVUS �� !"#$%&'( PCI�� 30%�
� �� !"#
�� ��� !��cutting balloon���� ��� !"#$%&'()*
�� �� !"#$�� !"�cutting balloon���� !"#$%&'(
��
1��� !"#�� !" 10�� �
2��� !"#$%&
3��� !"
� �� !"#$%&' �� !"#$ %&'( )*+,�
�� ��� !"#$%&'()*+,�� !"#$%&'(
�� !"#$%&'()*+,-./0
1�CRT�� !"#$%&'()*+,-.()*/0123
2��� !"#$%&'()*+,-./��0,-.12345
�� !"#$%&'()*+,-./0123456789: 1~2�
�� !"#$%&'()*+,-./0123'4567'89�
�� !"#
�� �� !"#$%& renew�� !"#$%&'()*+,-./01
�� !"#$%&'()*%&'+,-./0123456789:
�� !
� �� ��
�� !"#$
����� !"#$%&'()*+,-.
�� �� ��a��� !"#$%&'()�� !"#$%&'(��
�� !"#$%&'()*+,-./01�b��� !"#$%&
�� !"#$%
� �� 1��� !"#$%&'�� !"#$%&'()*+,-(.��/
�� !�"#
�� !"#$
�� !
96 � 6 ��62
�� !"#$%&'()*+,-./01
2��� !"#$%&'(�� !"#$%&'()*+,-./01
�� !"#$%&'(
�� �� !"#$%&'() stress echo, contrast echo� 3D echo�� !"#$%
� �� �� !"#$%&'()*+,-./0123456789:;<=
�� !"
�� !"
�� !�"#
�� !"#$
�� !
63
1 Acquired Arteriovenous �� !"#$%
Fistula
2 Acute and Subacute �� !��"#$%
Endocarditis
3 Acute Coronary Syndrome �� !"
4 Acute Myocardial Infarction �� !"#
5 Acute Myocarditis �� !"
6 Acute Pericarditis �� !"#
7 Acute Rheumatic Endocarditis�� !�"#$%
8 Acute Rheumatic Fever �� !"
9 Acute Rheumatic Myocarditis�� !�"#$
10 Acute Rheumatic Pericarditis�� !�"#$%
11 Acute Transmural Myocardial�� !"!�
Infarction of Anterior Wall �� !
12 Acute Transmural Myocardial�� !"!�
Infarction of Inferior Wall �� !
13 Alcoholic Cardiomyopathy �� !"#$
14 Angina Pectoris ��
15 Angina Pectoris, Variant �� !"#
16 Angioplasty �� !"
17 Anti-Arrhythmia Agents �� !"#$
18 Aortic Aneurysm and �� !"#$
Dissection
19 Aortic Insufficiency �� !"#$%
��Aortic Regurgitation�
20 Aortic Regurgitation �� !"#$%
��Aortic Insufficiency�
21 Aortic Valve �� !
22 Aortic Valve Disease �� !"#
23 Arrhythmia �� !
24 Arterial Embolism and �� !"# $%
Thrombosis
25 Artificial Heart �� !
26 Atherosclerosis �� !(�)��
27 Atrial Fibrillation and Flutter �� !"#!
28 Atrial Heart Septal Defects �� !"#
29 Atrioventricular and Left �� !"#$%&'
Bundle-branch Block
30 Balloon Angioplasty �� !"#$
31 Bicuspid Aortic Valve �� !"#
32 Budd-Chiari Syndrome Budd-Chiari�� !"
33 Carcinoid Heart Disease �� !"
34 Cardiac Arrest �� !
35 Cardiac Arrest with �� !"#$%&
Successful Resuscitation ��
36 Cardiomyopathy �� !
37 Cerebral Atherosclerosis (�)�� !"#$
(�)��
38 Cerebral Infarction ��
39 Cerebrovascular Diseases �� !"
40 Chagas Cardiomyopathy Chagas��
41 Chronic Adhesive Pericarditis�� !�"#$%
42 Chronic Constrictive �� !�"#$%
Pericarditis
43 Chronic Ischaemic Heart �� !�"#$
Disease
44 Circulatory and Respiratory �� !"#$
Physiology
45 Congenital Heart Defects �� !"#$
46 Congestive Cardiomyopathy�� !"#$
47 Congestive Heart Failure �� !"#
48 Coronary Aneurysm �� !"
49 Coronary Angiography �� !"#$%&
50 Coronary Arteriosclerosis �� !"#
51 Coronary Artery Aneurysm �� !"
52 Coronary Artery Bypass �� !"#
53 Coronary Atherectomy �� !"#$%
54 Coronary Care Units �� !"#
55 Coronary Circulation �� !
56 Coronary Disease �� !
57 Coronary Thrombosis �� !"#
58 Coronary Vasospasm �� !"#
59 Coronary Vessel Anomalies �� !"#
60 Coronary Vessels �� !
61 Crisscross Heart �� !
62 Diastolic Heart Failure �� !"#
63 Diastolic Murmur �� !"
64 Dilated Cardiomyopathy �� !"#$
65 Edema ��
66 Essential(primary) �� (�� )��
Hypertension
67 Fetal Heart Rate �� !"
68 Fetal Heart �� !
69 First Degree Atrioventricular �� !"#$%
Block
70 Heart ��
�� !"
No. �� �� No. �� ��
�� !�"#
�� !"#$
�� !
96 � 6 ��64
71 Heart Aneurysm ��
72 Heart Arrest �� !
73 Heart Atrium ��
74 Heart Auscultation �� !
75 Heart Block �� !"#
76 Heart Catheterization �� !"
77 Heart Conduction System �� !"#
78 Heart Diseases ��
79 Heart Failure �� !
80 Heart Function Tests �� !"#
81 Heart Injuries �� !
82 Heart Massage �� !
83 Heart Murmurs ��
84 Heart Neoplasms �� !
85 Heart Rate ��
86 Heart Rupture �� !
87 Heart Septal Defects �� !"#
88 Heart Septum �� !
89 Heart Sounds ��
90 Heart Transplantation �� !
91 Heart Valve Diseases �� !"
92 Heart Valve Prolapse �� !"
93 Heart Valve Prosthesis �� !"
94 Heart Valves ��
95 Heart Ventricle ��
96 Heart-Assist Devices �� !"#
97 Heart-Lung Machine ��
98 Heart-Lung Transplantation �� !
99 Hereditary Haemorrhagic �� !" #$
Telangiectasia �� !"
100 Hypertensive Encephalopathy�� !"#$
101 Hypertensive Heart Disease�� !"#$
102 Hypertensive Renal Disease�� !"#$
103 Hypertrophic Cardiomyopathy�� !"#$
104 Hypoplastic Left Heart �� !"#$%&
Syndrome
105 Hypotension ��
106 Idiopathic Hypotension �� !(��)��
��
107 Implantable Defibrillators �� !"#
108 Induced Heart Arrest �� !"#$%
109 Infective Endocarditis �� !"#$
110 Infective Myocarditis �� !"#
111 Infective Pericarditis �� !"#$
112 Internal Mammary-Coronary �� ! - �� !
Artery Anastomosis ��
113 Intracerebral Haemorrhage �� !
114 Ischaemic Cardiomyopathy �� !"#$
115 Ischaemic Heart Disease �� !"#
116 Isolated Myocarditis �� !"#
117 Laser Angioplasty �� !"#$
118 Laser-Assisted Balloon �� !"#$%
Angioplasty ��
119 Left Ventricular Failure �� !"
120 Left Ventricular Systolic �� !"#$%&
Dysfunction
121 Mitochondria, Heart �� !"
122 Mitral Insufficiency �� !"#$%&
Mitral Regurgitation�
123 Mitral Regurgitation �� !"#$%&
Mitral Insufficiency�
124 Mitral Stenosis �� !"
125 Mitral Valve Prolapse �� !"
126 Multiple Valve Diseases �(�)�� !
127 Myocardial Ischemic �� !"#$
Preconditioning
128 Myocardial Contraction �� !
129 Myocardial Depressant Factor�� !"#
130 Myocardial Diseases �� !
131 Myocardial Infarction �� !
132 Myocardial Ischemia �� !
133 Myocardial Reperfusion �� !"
134 Myocardial Reperfusion Injury�� !"#$
135 Myocardial Revascularization�� !"#$
136 Myocardial Stunning �� !"#$
137 Nonrheumatic Aortic Valve �� !"#$%
Disorders ��
138 Nonrheumatic Mitral Valve �� !"#$%&
Disorders
139 Non-ST-Segment Elevation � ST�� !"#
Myocardial Infarction �� !
140 Not Specified as �� !"#$
Haemorrhage or Infarction ��(�)��
Stroke
141 Obstructive Hypertrophic �� !"(�� !
Cardiomyopathy �)�� !"
142 Old Myocardial Infarction �� !"#$
143 Paroxysmal Tachycardia �� !"#$
144 Percutaneous Coronary �� !" #$%
Transluminal Angioplasty
No. �� �� No. �� ��
�� !�"#
�� !"#$
�� !
65
145 Pericardium ��
146 Phlebitis and �� !"#��
Thrombophlebitis
147 Portal Vein Thrombosis �(�)��
148 Post-Infarction Heart Rupture�� !"�#$
149 Pre-excitation Syndrome �� !"#$%
150 Premature Cardiac Complexes�� !"#$
151 Primary Pulmonary �� !"#$
Hypertension
152 Pulmonary Artery ��
153 Pulmonary Atresia �� !"
154 Pulmonary Circulation ��
155 Pulmonary Edema ��
156 Pulmonary Embolism ��
157 Pulmonary Heart Disease �� !
158 Pulmonary Hypertension �� !
159 Pulmonary Subvalvular �� !"#$
Stenosis
160 Pulmonary Valve �� !
161 Pulmonary Valve Disorders �� !"#
162 Pulmonary Valve Insufficiency�� !"#$%
163 Pulmonary Valve Stenosis �� !"#
164 Pulmonary Veins ��
165 Pulmonary Veno-Occlusive �� !"#$%
Disease
166 Pulmonary Vlave Insufficiency�� !"(�)��
167 Pulmonary Wedge Pressure�� !"
168 Raynaud's Syndrome ��(Raynaud)(�)
��
169 Renovascular Hypertension �� !"�#
170 Restrictive Cardiomyopathy�� !"#$
171 Rheumatic Aortic Insufficiency�� !"#$%
�� !
172 Rheumatic Aortic Stenosis �� !"#$%&
173 Rheumatic Aortic Valve �� !"#$%&
Diseases
174 Rheumatic Chorea �� !"#
175 Rheumatic Heart Disease �� !"#
176 Rheumatic Mitral Insufficiency�� !"#$%
��
177 Rheumatic Mitral Valve �� !"#$%
Diseases
178 Rheumatic Tricuspid Valve �� !"#$%
Diseases
179 Second Degree �� !"#$%
Atrioventricular Block
180 Secondary Hypertension �� !"#
181 Sick Sinus Syndrome �� !"
182 Silent Myocardial Ischaemia�� !"#$%
183 Sinus Arrhythmia �� !"#
184 ST-Elevation Myocardial ST�� !"#
Infarction �� !
185 Subarachnoid Haemorrhage �� !"#$
186 Subdural Haemorrhage �� !"
187 Supraventricular Tachycardia�� !�"#$
188 Systolic Murmur �� !"
189 Thromboangitis Obliterans �� !"!#$
�Buerger� �Buerger(�)��
190 Tricuspid Insufficiency �� !"#$%
191 Tricuspid Stenosis �� !"
192 Unstable Angina �� !"#$
193 Valve Unspecified �� !"#$%�
Endocarditis �
194 Varicose Veins �� !
195 Varicose Veins of Lower �� !"#
Extremities
196 Ventricular Arrhythmia ��� !"
197 Ventricular Fibrillation and �� !"#!
Flutter
198 Ventricular Heart Septal �� !"#
Defects
199 Ventricular Tachycardia ��� !"
No. �� �� No. �� ��
�� !�"#
�� !"#$
�� !
96 � 6 ��66
�� !"
�� !"#"$%&'()*+
���� !"#$%&�� !"#$ !%&'
1. �� !!"#$%&'()*+,-./01 234
2. �� !"#$%&'()!!*+,-./012(342567.)8 !9
�� !"!#$%&
3. �� !"#$%&'()"*+,-./(012345678��9:;<=>
4. �� !"#$%&'()*+,
5. ��� !"#$%&'()*"+,#-.!/
6. �� !"#$%&'($)*+,-./0123456��789:;<=>
�� !"#$%&'()*+,-. �*/0123456
7. �� !"#$%&'%()$*+(,-.$/012% 10�� !"# 8��
�� 6�� !"#$%&
8. �� !"#$%&' 16th APCC�� !"�� !��
�� ! "#$%&'()*+,-
�� !"#$%&'()*+,-(."!�� !"�� !"#$
���� !�� !"�� !"#$ !%&'
1. �� !"#$%&'()
2. �� !"#$% &'
3. �� !"#$%&'( !)*
4. �� !"#$%&'()*+,�� !"#$%&'�� !"#$%&'
5. �� !"#$�1��� !"#$�2��� !"#$%&'()*+,#-
�� !"#$�3��� !"#$%&'(
6. �� !"#$%&'(
7. �� ! "#$%& '(%)* + 10�� !"#$%&
8. �� !"#$ 16th APCC�� !"�� !��
�� ! "#$%&'()*+,-.
�� !"#$%&'()*+,-(."!�� !"�� !"#$
�� !�"#
�� !"#$
�� !
67
�� !"
Ten
tati
ve S
cien
tifi
c P
rog
ram
fo
r 16
th A
PC
C
�� !�"#
�� !"#$
�� !
96 � 6 ��68
�� !"
AMI Registry
�A��� !
���____________________________
�� !"�_____________________
�� !"�_____________________
���____________________________
�� !"_______________________�� _______________
����__________________________
�� !"#�___________________
�� !"_______________________
�� !"_______________________
�� !"#$�� !" #� _______________
�B�Risk factors
� Hypertension
� DM
� Dyslipidemia: � High TC, � High TG, � High LDL, � Low HDL-C
� Smoking
� Renal insufficiency
� High homocysteine
� High hsCRP
� Stroke
� PAD
� Family history of premature CAD
�C���
Chest pain onset time: �� !" #, _______________________
�� !�"#
�� !"#$
�� !
69
Killip Class: � I; � II, � III, � IV
EKG : � STEMI; � ant; � inf; � lat, � post, � others
� NSTEMI
� Others,�Specify�____________________________________________
Enzyme max. � CPK___________; � CK-MB___________; � TroI_________
Thrombolytics �� ; ��
�� ___________; �Time from onset, Hr:Min�______________
Drug used, dose and dosing schedule:________________________
_______________________________________________________
Angiography �� ; ��
�� __________; �Time from onset, Hr:Min�_______________
Findings: _______________________________________________
PCI �� ; ��
Balloon�� _________ ; �Time from onset�______________ ;
Target vessel�Segment:1-15�:_____________________________
Stenting �� ; �� ; �Number of stents�_________________;
� Bare-metal stent or � Drug eluting stent or � Other_______
Results: � Successful; � Fail; � Complication
�Go to PCI Registration Form�
LV systolic dysfunction,�� ; �� ; LVEF __________; Study method: � Echo;
� Ventriculography; � RNA; � Other__________________________
LV diastolic dysfunction�� ; ��
Cardiogenic shock �� ; ��
Heart block �� ; �� ; Specify___________________________________
CABG �� ; �� ; �� __________ ;�Time from onset�________
Re-infarction: �� ; �� ; �� __________
Medication: � Aspirin; � Beta blocker; � iv nitroglycerin; � inotropic agent�� dopamine;
� dobutamine; � Other�; � ACE-I; � ARB; � Statin; � CCB
IABP use: �� ; ��
�� !�"#
�� !"#$
�� !
96 � 6 ��70
ECMO use: �� ; ��
Other special procedure or treatment:_______________________________________
�D�Complications
Arrhythmia: �� ; �� ;
�VT: �� ; �� ; VF: �� ; �� ; Af: �� ; �� ; APC: �� ; �� ;
�VPC: �� ; �� ; PSVT: �� ; ��
Significant MR:�� ; �� ; Time_________________________________________
VSD: �� ; �� ; Time_________________________________________
Free wall cardiac rupture: �� ; �� ; Time ________________________________
LV aneurysm: �� ; �� ; Time _________________________________________
�E�Outcome � Stable discharge
� Transfer to other hospital; Time�D/M/Y�_________________
� Critical�AA�discharge; Time�D/M/Y�_________________
� Expired in the hospital; Time�D/M/Y�_________________
�� !�"#
�� !"#$
�� !
71
PCI Registry
�A����____________________________
�� !"�_____________________
�� !"�_____________________
���____________________________
�� !"_______________________�� _______________
����__________________________
�� !"#�___________________
�� !"_______________________
�� !"_______________________
�B�Risk factors
� Hypertension
� DM
� Dyslipidemia: � High TC, � High TG, � High LDL, � Low HDL-C
� Smoking
� Renal insufficiency
� Homocysteine
� HsCRP
� Stroke
� PAD
� Family history of CAD
�C�PCI:
� IVD, � 2VD, � 3VD
�����Lesion 1�����
Special Lesions� LM, � CTO, � Long�diffuse�, � Bifurcation, � SVG, � LIMA,
� Ostium, � Thrombus, � Others__________________
�� !�"#
�� !"#$
�� !
96 � 6 ��72
Lesion Type: � De Novo, � Restenosis�POBA�, � ISR�BMS�, � ISR�DES�
Anatomy:�1-15�� Type A, B1, B2, C�_____________________________________
Reference Diammeter�mm�______________________________________
MLD�mm�____________________________________________________
Lesion Length�mm�____________________________________________
Q/A Stenosis�%�_______________________________________________
TIMI flow �0-3�_______ , Thrombus�+or-�________ , collaterals from_________
POBA: _____________________________________________________
Rotablation: _________________________________________________
Stent:�BMS�: _________________________ , �mm�_____x_____
Stent�DES�: � CYPHER � TAXUS � ENDEAVOR � XIENCE, �mm�_____x _____
� Others________________________________________
Residual Stenosis�%�___________
�����Lesion 2�����
�D�Basic data:
Test: � TET, � RNA, � Stress echo, � MRA, � MDCT, � others__________
LV systolic dysfunction,�� ; �� ; LVEF______; Study method: � Echo;
� Ventriculography; � RNA; � Other___________
LV diastolic dysfunction�� ; ��
� Renal insufficiency
Medication:� Aspirin, � Clopidogrel, � Beta blocker, � ACEI, � ARB
� Statin, � CCB, � Coronary Dilators, � others______________
�E�Procedures:
� Elective; � Emergency; � Stable angina; � ACS excluding STEMI; � STEMI
� Radial a, � Femoral a, � Brachial a, � Ulnar a, � others________________
� IVUS, � Virtual Histology
� Other image____________
�� !�"#
�� !"#$
�� !
73
� Dissection, � No Reflow, � Acute Closure, � Perforation, � New thrombus, � others
� IABP
� IIb/IIIa, � others______________
Fluoro time______________minutes
Contrast volume_______________cc
�F�Complications
Arrhythmia: � VT, � VF, � Af, � PSVT, � Heart block
� AMI
� Shock
� Acute lung edema
� Tamponade
� Stroke, � Distal embolization
� Emergency OP, � Emergency Re-PCI
� Mortality
� CIN�Contrast induced nephropathy�
� Hemorrhage, requiring blood transfusion
� Others______________
�G�Outcome: Procedure result:� Optimal; � Suboptimal; � Failure
Discharge: � Stable discharge
� Transfer to other hospital; Time�D/M/Y�________________
� Critical�AA�discharge; Time�D/M/Y�________________
� Expired in the hospital; Time�D/M/Y�________________
�� !�"#
�� !"#$
�� !